Company intelligence / Profile preview

CVIS

Sunnyvale, California, United States

Ownership: Private
Development stage: Other

Overview

Cardiovascular Imaging Systems (CVIS) was a pioneering medical technology company focused on the development and commercialization of intravascular ultrasound (IVUS) imaging systems. The company's technology provided high-resolution, cross-sectional images of the interior of coronary arteries, allowing clinicians to better visualize plaque and guide interventional procedures such as angioplasty and stenting. CVIS played a critical role in establishing IVUS as a standard diagnostic tool in interventional cardiology. The company was eventually acquired by Boston Scientific, where its technology became a foundational component of their cardiovascular imaging portfolio.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Medical Imaging

Beyond the preview

Go deeper on CVIS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CVIS.

Explore the full profile